Data / Form D filings / ReNetX Bio, Inc.
ReNetX Bio, Inc.: Form D filings
ReNetX Bio, Inc., a biotechnology company in New Haven, CT, filed 6 Form D notices with the SEC between 2010 and 2020. The latest, on September 28, 2020, reports $2.8 million sold of a $2.8 million offering to 6 investors.
Find out what ReNetX Bio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 157 CHURCH STREET, 19TH FLOOR, New Haven, CT, 06510
- Phone
- (203) 444-6642
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1486634
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2020 | Amendment | $2,800,000 | $2,800,000 | $0 | 6 | Nov 27, 2019 | sec.gov |
| Dec 2, 2019 | New notice | $5,500,000 | $1,349,999 | $4,150,001 | 1 | Nov 27, 2019 | sec.gov |
| Jul 9, 2019 | Amendment | $3,193,548 | $3,193,548 | $0 | 6 | Mar 29, 2018 | sec.gov |
| Apr 9, 2018 | New notice | $2,800,000 | $1,681,998 | $1,118,002 | 5 | Mar 29, 2018 | sec.gov |
| Dec 29, 2017 | New notice | $450,000 | $425,000 | $25,000 | 5 | Jul 18, 2017 | sec.gov |
| Apr 14, 2010 | New notice | $757,971 | $757,971 | $0 | 1 | Apr 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory Ho | Director | |
| Erika Smith | Executive Officer, Director | |
| John Puziss | Director | |
| George Maynard | Executive Officer | |
| David Wurzer | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Sep 28, 2020 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ReNetX Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.